BridgeMD
New treatment option for Postoperative Cognitive Dysfunction
Official title Use of Transcranial Magnetic Stimulation in the Post-Operative Cognitive Dysfunction in Elderly
ClinicalTrials.gov ID: NCT06658769
What this study is testing
- What it's testing
- Postoperative Cognitive Dysfunction (POCD) is a prevalent condition with significant clinical, social, and financial impacts on patients and healthcare services. The term POCD refers to any signs of new cognitive impairment that exceed the expected time for recovery from the acute effects of surgery and anesthesia.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 120
You may be able to join if
- Patients over 60 years old
- Patients scheduled for elective surgeries of moderate or large scale and candidates for general or spinal anesthesia;
- Patients who demonstrate possible or probable cognitive impairment based on pre-operative screening using the 10-CS (10-point cognitive screening)...
You likely can't join if
- Contraindications for the use of Transcranial Magnetic Stimulation (metal implants in the head, history of seizures or epilepsy, brain trauma or...
- Medical diagnosis of Major Neurocognitive Disorder (any form of dementia, regardless of the stage);
- Indication for skull surgery;
- Conditions that interfere with cognitive testing (presence of severe hearing and vision loss, inability to understand Portuguese);
- Ongoing medication adjustments that affect cortical electrical activity (antidepressants, antipsychotics);
- Difficulty attending treatment during the stipulated evaluation and follow-up period, whether due to socioeconomic or clinical reasons;
See the full eligibility criteria
- Patients over 60 years old
- Patients scheduled for elective surgeries of moderate or large scale and candidates for general or spinal anesthesia;
- Patients who demonstrate possible or probable cognitive impairment based on pre-operative screening using the 10-CS (10-point cognitive screening) tool; - For Non-surgical Control Intervention Group, only the first and...
- Contraindications for the use of Transcranial Magnetic Stimulation (metal implants in the head, history of seizures or epilepsy, brain trauma or surgery, intracranial hypertension, and complications from exposure to...
- Medical diagnosis of Major Neurocognitive Disorder (any form of dementia, regardless of the stage);
- Indication for skull surgery;
- Conditions that interfere with cognitive testing (presence of severe hearing and vision loss, inability to understand Portuguese);
- Ongoing medication adjustments that affect cortical electrical activity (antidepressants, antipsychotics);
- Difficulty attending treatment during the stipulated evaluation and follow-up period, whether due to socioeconomic or clinical reasons;
- Anticipation of surgical scheduling;
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 120 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.